Avita Medical | 1811094D - 市值



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 368.7M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


市值 更改 日
Clinuvel Pharmaceuticals AUD 625.5M 105.22M 2025-12
Cochlear AUD 17.05B 2.6B 2025-12
CSL USD 55.89B 20.42B 2025-12
Cspc Pharmaceutical CNY 103.79B 16.5B 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Divis Laboratories Ltd INR 1.75T 167.78B 2026-06
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Medical Developments International AUD 62.53M 563.29K 2025-12
Nanosonics AUD 1.2B 25.43M 2025-12
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 252.47M 59.69M 2026-03
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pacific Edge NZD 177.94M 16.27M 2026-06
Paradigm Biopharmaceuticals AUD 145.7M 26.92M 2025-12
Pharma Mar EUR 1.31B 263.2M 2026-06
PYC Therapeutics AUD 965.3M 209.97M 2025-12
Qiagen NV USD 8.07B 197.36M 2026-06
Ramsay Health Care AUD 7.93B 537.83M 2025-12
ResMed USD 47.56B 4.96B 2026-03
Sartorius EUR 15.63B 1.38B 2026-06
Telix Pharmaceuticals AUD 7.81B 2.74B 2026-06
Zealand Pharma A/S 20.84B 12.51B 2026-03
Zz Pientze Pharmaceu CNY 65.93B 25.23B 2026-06